2022
210.15: MRNA Based Vaccines Against SARS-CoV-2 Do Not Alter cPRA in Patients Awaiting Kidney Transplant
Rewinski M, Doyle P, Durkin D, Vicki S, Devivo J, Caruk R, Haberman A, Palmeri D, Cyr P, Morgan G, Serrano O, Emmanuel B, Ebcioglu Z, Singh J, Kent R, Ye X, Tremaglio J, Bow L, Dar W. 210.15: MRNA Based Vaccines Against SARS-CoV-2 Do Not Alter cPRA in Patients Awaiting Kidney Transplant. Transplantation 2022, 106: s9-s10. DOI: 10.1097/01.tp.0000885248.19450.6c.Peer-Reviewed Original Research
2018
P026Timing is everything – Even for DP antibodies
Rewinski M, Doyle P, Bow L. P026Timing is everything – Even for DP antibodies. Human Immunology 2018, 79: 80. DOI: 10.1016/j.humimm.2018.07.084.Peer-Reviewed Original ResearchDonor-specific antibodiesTransplant glomerulopathyKidney transplantSensitizing eventsAbsence of DSADevelopment of DSALevels of DSADeceased donor kidney transplantDP typingPotential sensitizing eventsReduced graft survivalDonor kidney transplantsArteriolar hyalinosisBK viremiaKidney TxNegative XMPositive XMStandard immunosuppressionCNI toxicityGraft survivalBlood transfusionGraft failureAntibody testingAntibody responseDP antigensP032 Edta elucidates unexpected crossmatch results
Rewinski M, Doyle P, DeVivo J, Vicki S, Durkin D, Bow L. P032 Edta elucidates unexpected crossmatch results. Human Immunology 2018, 79: 84. DOI: 10.1016/j.humimm.2018.07.090.Peer-Reviewed Original ResearchPatient seraAntibody profileDeceased donor kidney transplantClass IDonor kidney transplantsKidney TxDSA levelsKidney transplantFlow crossmatchUnacceptable antigensCrossmatch resultsT cellsMFI levelsAb reactivityAntibody detectionAsian malesPossible epitopesCourse of monthsSerumAb profilesAO treatmentSignificant differencesSignificant increaseTreatmentDD cells
2015
Case study: Use of A2 and donor red blood cells for anti ABO a titer
Miller M, Bow L. Case study: Use of A2 and donor red blood cells for anti ABO a titer. Human Immunology 2015, 76: 97. DOI: 10.1016/j.humimm.2015.07.141.Peer-Reviewed Original ResearchDonor RBCsIgG titersABO incompatibilityTransplant programsBlood group O recipientsBlood group A antigensWeak antigen expressionABO-incompatible transplantsGroup O recipientsBlood group OYear old maleGroup A antigensBlood group AA1 RBCsABOi transplantsIncompatible transplantsKidney transplantationRecipient serumAbsolute contraindicationKidney transplantRed blood cellsAntibody titersAntigen subtypesO recipientsIgG antibodies
1988
Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer R, Bow L, Roper L, Hull D, Bartus S. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression. Clinical Transplants 1988, 147-58. PMID: 3154467.Peer-Reviewed Original ResearchConceptsLiving-related donor kidney transplantsDonor kidney transplantsCadaver kidney transplant recipientsKidney transplant recipientsGraft survivalKidney transplantOKT3 therapyTriple immunosuppressionTransplant recipientsHartford HospitalControl groupPretransplant blood transfusionsPrevious control groupSteroid-resistant rejectionUse of OKT3Year graft survivalMean serum creatinineEuro-Collins solutionAddition of CsAKidney transplantationRenal transplantationCMV infectionSerum creatinineBlood transfusionDR matching